Antidepressant short-term and long-term brain effects during self-referential processing in major depression.

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Major depressive disorder (MDD) is linked to abnormal self-referential processing.
• The neural mechanisms underlying this impairment and the impact of antidepressants remain unclear.
• Understanding these effects is crucial for developing targeted depression treatments.

Purpose of the Study:

• To investigate the short- and long-term effects of agomelatine on neural self-referential processing in depressed patients.
• To explore the association between baseline brain activation and 6-month depression remission.
• To compare agomelatine's effects with placebo and healthy volunteer responses.

Main Methods:

• A randomized, double-blind, placebo-controlled functional magnetic resonance imaging (fMRI) study.
• 25 outpatients with depression underwent three fMRI scans (baseline, 1 week, 7 weeks) during an emotional self-referential task.
• Treatment involved 1 week of agomelatine or placebo, followed by 24 weeks of agomelatine for all patients; 14 healthy volunteers served as controls.

Main Results:

• After 7 days, agomelatine-treated patients showed normalized ventrolateral prefrontal cortex deactivation during self-referential tasks.
• By 7 weeks, patients exhibited increased ventral anterior cingulate cortex activation.
• Baseline dorsomedial prefrontal cortex and precuneus activation predicted treatment response at 24 weeks.

Conclusions:

• Agomelatine exerts short- and long-term effects on brain regions critical for emotional regulation and anhedonia in depression.
• Baseline activation in the dorsomedial prefrontal cortex and precuneus may serve as biomarkers for predicting depression remission.
• These findings support agomelatine's efficacy and highlight potential neurobiological markers for personalized depression treatment.